GRAFTON DBM contains demineralized human bone tissues recovered from cadaveric donors using aseptic surgical techniques, and is microbiologically tested during recovery. It is combined with USP anhydrous glycerol to yield a demineralized bone matrix (DBM) allograft product.

GRAFTON DBM are demineralized bone allograft products that are absorbed/remodeled and replaced by host bone during the healing process. Average resorption time is 2~3 months. GRAFTON® Demineralized Bone Matrix is indicated as a bone graft extender, bone graft substitute, and bone void filler to fill bony voids or gaps not intrinsic to the stability of the bony structure.

By:

SwissBone® is a new hybrid reinforced bioactive bone substitute specifically developed for bone regeneration in reconstructive surgery. SwissBone® is produced by combining a bovine mineral bone matrix with bioactive resorbable polymers and collagen fragments. This new concept of composite biomaterial allows growth of the patient’s cells into SwissBone® while its biopolymers degrade, providing integration and osteogenesis.

By:

Medical-grade Polyporous Resorbable Ceramic Granules composed of 15% hydroxyapatite (Ha) and 85% beta-tricalcium phosphate (B-TCP). MASTERGRAFT® Resorbable Ceramic Granules are indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure.

By: